Tresmares Capital has taken a minority stake in Rioja Nature Pharma
Madrid – CFI is pleased to announce that it acted as exclusive financial advisor to Rioja Nature Pharma in its sale of a minority stake to Tresmares Capital through a sharecapital increase.
Rioja Nature Pharma is a leading dietary supplements manufacturer for third parties with expected revenues of >€40M in 2023.
Tresmares Capital is a pan-European growth-focused alternative investment firm operating in Spain, the United Kingdom and Portugal. Founded in 2020 and comprising a team of 50 investment professionals, the firm offers an extensive range of financing solutions to both high-growth SMEs and their private equity backers.
This transaction closed in November 2023.
Food & Beverage & Agribusiness

has sold minority stake to

Transaction details
Leading dietary supplement provider Rioja Nature Pharma has sold a minority stake to private equity fund Tresmares Capital
This transaction was advised by:

Manuel UrÃbarri
Partner, Managing DirectorOur latest transactions
Real Estate & Construction

has been acquired by

Transaction details
Blue Bay Building Products has been acquired by Wolseley Group, a leading specialist provider of plumbing, heating, cooling, and utility products to trade customers
Food & Beverage & Agribusiness

has sold

to

Transaction details
Fleury Michon has sold Room Saveurs, a trading company and laboratory specialized in the development of meal trays, to Kumo
Industrials

has transferred the equity interests of its subsidiary

to

Transaction details
Maezawa Kyuso Industries has transferred the equity interests of Maezawa Kyuso (Nanchang) to Guangzhou Hongxing Investment Co., Ltd.
Software & IT Services

have sold

to
a portfolio company of

Transaction details
Companyweb, the leading provider of subscription-based credit information and private company data intelligence in Belgium, has been sold to Altares, a provider of B2B data solutions, servicing medium and large companies across the entire data value chain